share_log

翰森製藥：截至二零二四年一月三十一日止月份之股份發行人的證券變動月報表

HANSOH PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

香港交易所 ·  Feb 1 04:14
Summary by Moomoo AI
翰森製藥於2024年2月1日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年1月31日的公司股份變動情況。報告顯示，翰森製藥的法定/註冊股本及已發行股份在該月份均無變動，維持在20,000,000,000股，每股面值0.00001港元，總股本為200,000港元。此外，報告提到，公司於2021年1月22日發行的、將於2026年到期的零息可換股債券，已於本月按照條款及條件進行贖回，贖回本金總額為590,622,000美元。根據每股轉換價59.33港元及固定匯率計算，本月底可能發行的新股份數目為702,765股。報告最後確認，本月沒有發行新證券，並由聯席公司秘書鍾勝利女士呈交。
翰森製藥於2024年2月1日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年1月31日的公司股份變動情況。報告顯示，翰森製藥的法定/註冊股本及已發行股份在該月份均無變動，維持在20,000,000,000股，每股面值0.00001港元，總股本為200,000港元。此外，報告提到，公司於2021年1月22日發行的、將於2026年到期的零息可換股債券，已於本月按照條款及條件進行贖回，贖回本金總額為590,622,000美元。根據每股轉換價59.33港元及固定匯率計算，本月底可能發行的新股份數目為702,765股。報告最後確認，本月沒有發行新證券，並由聯席公司秘書鍾勝利女士呈交。
Hansen Pharmaceuticals filed an updated Securities Monthly Change Report with Hong Kong Trading and Clearing Limited on February 1, 2024, reporting the changes in the company's shares for the year ended January 31, 2024. The report shows that Hanson Pharmaceuticals' regulary/registered share capital and issued shares remained unchanged during the month at 20,000,000,000 shares with a face value of HK$0.00001 per share and a total share capital of HK$200,000. In addition, the report notes that the Company issued on January 22, 2021, which will mature in 2026, has been redeemed on terms and conditions this month for a total redemption amount of $590,622,000. Based on the conversion price of HK$59.33 per share and the constant exchange rate, the number of new shares that may be issued at the end of this month is 702,765 shares. The report finally confirms that no new securities have been issued this month and was presented by Ms Chung Shengli, Joint Corporate Secretary.
Hansen Pharmaceuticals filed an updated Securities Monthly Change Report with Hong Kong Trading and Clearing Limited on February 1, 2024, reporting the changes in the company's shares for the year ended January 31, 2024. The report shows that Hanson Pharmaceuticals' regulary/registered share capital and issued shares remained unchanged during the month at 20,000,000,000 shares with a face value of HK$0.00001 per share and a total share capital of HK$200,000. In addition, the report notes that the Company issued on January 22, 2021, which will mature in 2026, has been redeemed on terms and conditions this month for a total redemption amount of $590,622,000. Based on the conversion price of HK$59.33 per share and the constant exchange rate, the number of new shares that may be issued at the end of this month is 702,765 shares. The report finally confirms that no new securities have been issued this month and was presented by Ms Chung Shengli, Joint Corporate Secretary.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more